Back to Agenda
Session 2 Track A: Health Canada Activities in the Medical Devices Area During the COVID-19 Pandemic
Session Chair(s)
Patrick Fandja, MBA, MS
Director, Bureau of Biologics, Radiopharmaceuticals and Self-care products, Health Canada, Canada
At the onset of the COVID-19 pandemic, Health Canada introduced a number of innovative and agile regulatory measures to facilitate access of medical devices needed for COVID -19, to Canadians and healthcare workers. These measures cover the lifecycle of medical devices; clinical trials for COVID-19, In Vitro diagnostic testing devices for COVID-19, post-market surveillance, Medical Device Establishment Licences and Inspection. The objective of this session is to provide an overview of Health Canada’s activities in the medical devices area during the COVID-19 pandemic.
Learning Objective : At the conclusion of this session, participants should be able to:
- Outline Health Canada’s activities in Clinical Trials and Post-market surveillance of COVID-19 devices
- Gain awareness of COVID-19 testing technologies approved by Health Canada
- Outline Health Canada’s activities in Medical Establishment Licences and Inspection during COVID-19 Pandemic
Speaker(s)
Clinical Trials and Post-market Surveillance of COVID-19 Medical Devices
Tanya Ramsamy, PhD
Executive Director, Medical Device Directorate , Health Canada, Canada
COVID-19 Testing Devices
Christine Leckie
A/Executive Director, Medical Device Directorate, Health Canada, Canada
Medical Devices Establishment Licenses and Inspections
Marie Odile N. Gomis, MS
Manager, Regulatory Operations and Enforcement Branch, Health Canada, Canada
Have an account?